Evgen Pharma PLC Holding(s) in Company (3770T)
17 Luglio 2020 - 1:05PM
UK Regulatory
TIDMEVG
RNS Number : 3770T
Evgen Pharma PLC
17 July 2020
TR-1: NOTIFICATION OF MAJOR INTEREST
IN SHARES(i)
1. Identity of the issuer or the underlying Evgen Pharma plc
issuer
of existing shares to which voting rights
are
attached: (ii)
------------------------------------------------
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
--------------------------------------------------------------------------------------------------------------
An acquisition or disposal of qualifying financial instruments
which may result in the acquisition of shares already issued to
which voting rights are attached
--------------------------------------------------------------------------------------------------------------
An acquisition or disposal of instruments with similar economic
effect to qualifying financial instruments
--------------------------------------------------------------------------------------------------------------
An event changing the breakdown of voting rights
--------------------------------------------------------------------------------------------------------------
Other (please change in percentage of voting rights arising
specify): upon a new issue of shares by the issuer
------------------------------------------------------------- -----------------------------------------------
3. Full name of person(s) subject Enterprise Ventures Limited
to the
notification obligation: (iii)
------------------------------------------------
4. Full name of shareholder(s) South Yorkshire Investment Fund Limited
(if different from 3.):(iv)
------------------------------------------------
5. Date of the transaction and 15(th) July 2020
date on
which the threshold is crossed
or
reached: (v)
------------------------------------------------
6. Date on which issuer notified: 17(th) July 2020
------------------------------------------------
7. Threshold(s) that is/are crossed
or
reached: (vi, vii) 1%
------------------------------------------------
8. Notified details:
A: Voting rights attached to shares (viii, ix)
Class/type Situation previous Resulting situation after the triggering
of to the triggering transaction
shares transaction
if possible
using
the ISIN CODE
------------------------------------ --------------------------------------------------
Number Number Number Number of voting % of voting
of of of rights rights
Shares Voting shares
Rights
---------------------- ------------ --------- ------------------- ------------------
Direct Direct Indirect Direct Indirect
(xi) (i)
--------- ----------- ------------ --------- -------- --------- ------- ---------
GB00BSVYN304 1,394,550 1,394,550 Nil Nil Nil Nil Nil
---------------------- ------------ --------- -------- --------- ------- ---------
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of Expiration Exercise/ Number of voting % of voting
financial date (xiii) Conversion rights that may rights
instrument Period be
(xiv) acquired if the
instrument is
exercised/ converted.
---------------------- ------------ ------------------------------ ------------------
None
---------------------- ------------ ------------------------------ ------------------
C: Financial Instruments with similar economic effect to Qualifying
Financial Instruments (xv, xvi)
Resulting situation after the triggering transaction
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
--------- ----------- ------------ ------------------- -----------------------------
None Nominal Delta
--------- ----------- ------------ ------------------- --------- ------------------
Total (A+B+C)
Number of voting rights Percentage of voting rights
--------------------------------------------------
Nil Nil
--------------------------------------------------
9. Chain of controlled undertakings through which the voting rights
and/or the
financial instruments are effectively held, if applicable: (xxi)
Proxy Voting:
10. Name of the proxy holder:
----------------------------
11. Number of voting rights proxy holder will
cease
to hold:
----------------------------
12. Date on which proxy holder will cease to
hold
voting rights:
----------------------------
13. Additional information:
14. Contact name: Enterprise Ventures Limited
----------------------------
15. Contact telephone number: 01772 270 570
----------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
HOLKZGMNGNLGGZM
(END) Dow Jones Newswires
July 17, 2020 07:05 ET (11:05 GMT)
Grafico Azioni Evgen Pharma (LSE:EVG)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Evgen Pharma (LSE:EVG)
Storico
Da Lug 2023 a Lug 2024
